These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 12063908)

  • 21. Premenstrual dysphoric disorder: burden of illness and treatment update.
    Pearlstein T; Steiner M
    J Psychiatry Neurosci; 2008 Jul; 33(4):291-301. PubMed ID: 18592027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacotherapy of premenstrual syndromes and premenstrual dysphoric disorder: current practices.
    Mitwally MF; Kahn LS; Halbreich U
    Expert Opin Pharmacother; 2002 Nov; 3(11):1577-90. PubMed ID: 12437492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluctuating serotonergic function in premenstrual dysphoric disorder and premenstrual syndrome: findings from neuroendocrine challenge tests.
    Inoue Y; Terao T; Iwata N; Okamoto K; Kojima H; Okamoto T; Yoshimura R; Nakamura J
    Psychopharmacology (Berl); 2007 Feb; 190(2):213-9. PubMed ID: 17072588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of premenstrual dysphoric disorder with selective serotonin reuptake inhibitors.
    Luisi AF; Pawasauskas JE
    Pharmacotherapy; 2003 Sep; 23(9):1131-40. PubMed ID: 14524645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Premenstrual dysphoric disorder: approach and treatment].
    Bianchi-Demicheli F; Lüdicke F; Campana A
    Gynecol Obstet Fertil; 2003 Jan; 31(1):49-54. PubMed ID: 12659785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of premenstrual dysphoric disorder with the GABA
    Bixo M; Ekberg K; Poromaa IS; Hirschberg AL; Jonasson AF; Andréen L; Timby E; Wulff M; Ehrenborg A; Bäckström T
    Psychoneuroendocrinology; 2017 Jun; 80():46-55. PubMed ID: 28319848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Premenstrual dysphoric disorder: diagnosis and therapeutic strategy].
    Bianchi-Demicheli F
    Rev Med Suisse; 2006 Feb; 2(52):393-4, 397-9. PubMed ID: 16523546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapid response to fluoxetine in women with premenstrual dysphoric disorder.
    Steinberg EM; Cardoso GM; Martinez PE; Rubinow DR; Schmidt PJ
    Depress Anxiety; 2012 Jun; 29(6):531-40. PubMed ID: 22565858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of premenstrual dysphoric disorder.
    Rapkin AJ; Lewis EI
    Womens Health (Lond); 2013 Nov; 9(6):537-56. PubMed ID: 24161307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Premenstrual Dysphoric Disorder.
    Lanza di Scalea T; Pearlstein T
    Psychiatr Clin North Am; 2017 Jun; 40(2):201-216. PubMed ID: 28477648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pretreatment pattern of symptom expression in premenstrual dysphoric disorder.
    Pearlstein T; Yonkers KA; Fayyad R; Gillespie JA
    J Affect Disord; 2005 Apr; 85(3):275-82. PubMed ID: 15780697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A review of treatment and management modalities for premenstrual dysphoric disorder.
    Kelderhouse K; Taylor JS
    Nurs Womens Health; 2013; 17(4):294-305. PubMed ID: 23957795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Double-blind, placebo-controlled pilot study of adjunctive quetiapine SR in the treatment of PMS/PMDD.
    Jackson C; Pearson B; Girdler S; Johnson J; Hamer RM; Killenberg S; Meltzer-Brody S
    Hum Psychopharmacol; 2015 Nov; 30(6):425-34. PubMed ID: 26193781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Premenstrual dysphoric disorder--review of actual findings about mental disorders related to menstrual cycle and possibilities of their therapy.
    Zukov I; Ptácek R; Raboch J; Domluvilová D; Kuzelová H; Fischer S; Kozelek P
    Prague Med Rep; 2010; 111(1):12-24. PubMed ID: 20359434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Assessment of premenstrual dysphoric disorder symptoms: population of women in Casablanca].
    McHichi alami Kh; Tahiri SM; Moussaoui D; Kadri N
    Encephale; 2002; 28(6 Pt 1):525-30. PubMed ID: 12506265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Premenstrual syndrome and premenstrual dysphoric disorder: definitions and diagnosis.
    Freeman EW
    Psychoneuroendocrinology; 2003 Aug; 28 Suppl 3():25-37. PubMed ID: 12892988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Premenstrual dysphoric disorder. An update.
    Steiner M
    Gen Hosp Psychiatry; 1996 Jul; 18(4):244-50. PubMed ID: 8832257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Premenstrual dysphoric disorder. An overview of diagnosis, epidemiology and therapeutic approaches].
    Lenzinger E; Diamant K; Vytiska-Binstorfer E; Kasper S
    Nervenarzt; 1997 Sep; 68(9):708-18. PubMed ID: 9411273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intermittent luteal phase sertraline treatment of dysphoric premenstrual syndrome.
    Halbreich U; Smoller JW
    J Clin Psychiatry; 1997 Sep; 58(9):399-402. PubMed ID: 9378691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Premenstrual syndrome.
    Yonkers KA; O'Brien PM; Eriksson E
    Lancet; 2008 Apr; 371(9619):1200-10. PubMed ID: 18395582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.